Notably, CRISP3-mediated upregulation of IL-17 in BC cells (Figure 9L) may contribute to the enrichment of Th17 and γδ T lymphocytes observed in the high-risk group (Figure 7), suggesting a potential feed-forward loop between tumor-intrinsic signaling and immune microenvironment remodeling. Here, CRISP3 is linked to breast cancer.